Remove Asset Allocation Remove Pharmaceutical Remove Valuation
article thumbnail

March Madness: Final Four Investing Bracket 2025

Dear Mr. Market

Historically, this bracket has been dominated by the tech sector, but after years of outsized gains, big tech valuations are stretched. However, Eli Lillys strong market position and the expanding global healthcare demand position it well for sustained growth, especially in the pharmaceutical sector.

article thumbnail

March Madness: Final Four Investing Bracket 2023 

Dear Mr. Market

IBM loses to QCOM based on valuation. Sticking back to the balancing theme of quality businesses, great valuations, meshed with the reward of a dividend, you get Ford yielding 4.62% and Conoco only at 2.16% but trading for a bargain P/E of 7. ARVN ) and #2 Rocket Pharmaceuticals, Inc. RCKT )… (previous pun intended!),

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Capital Markets: The Essence of American Capitalism | Weekly Market Commentary | July 03, 2023

James Hendries

This year, cross border activity has focused on the pharmaceutical sector as well as metals and mining. While this latest rally may have outpaced fundamentals in the short term, from a technical analysis perspective, and valuations look full, at the same time, the resilience of the U.S. Globally, approximately $1.22

article thumbnail

Investment Perspectives | Confidence

Brown Advisory

Equity returns are less predictable, but we believe they are more likely than not to be lower going forward compared to the post-crisis period, given the outlook for modest GDP growth around the world alongside today’s elevated valuations. A core allocation to high-grade bonds can play a similar role.

article thumbnail

Investment Perspectives | Confidence

Brown Advisory

Equity returns are less predictable, but we believe they are more likely than not to be lower going forward compared to the post-crisis period, given the outlook for modest GDP growth around the world alongside today’s elevated valuations. A core allocation to high-grade bonds can play a similar role.

article thumbnail

Transcript: Lisa Shalett, CIO Morgan Stanley

The Big Picture

She was CIO at Merrill Lynch Asset Management, and now CIO at both Morgan Stanley Wealth Management and runs their asset allocation models and their outsourced chief investment officer models. 00:20:56 [Speaker Changed] So, so let’s talk a little bit about what goes into managing a hundred plus billion dollars in assets.

article thumbnail

Transcript: Richard Bernstein

The Big Picture

He launched his own firm right into the teeth of the collapse in ’09, which turned out to be quite a fortuitous time to launch an asset management shop. Everybody wants to sell a company when they get a good valuation. Obviously, profits, very important to company valuation — BERNSTEIN: Absolutely. BERNSTEIN: Correct.

Economy 162